Home/Filings/4/0001764013-22-000097
4//SEC Filing

Fromkin Andrew J. 4

Accession 0001764013-22-000097

CIK 0001764013other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 4:48 PM ET

Size

7.4 KB

Accession

0001764013-22-000097

Insider Transaction Report

Form 4
Period: 2022-08-17
Transactions
  • Award

    Common Stock

    2022-08-17+21,05988,485 total
  • Award

    Stock Option (right to buy)

    2022-08-17+31,66831,668 total
    Exercise: $4.99Exp: 2032-08-17Common Stock (31,668 underlying)
Footnotes (3)
  • [F1]Represents the number of shares underlying restricted stock units awards ("RSUs").
  • [F2]The RSUs vest in their entirety one year after the date of grant on August 17, 2023, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
  • [F3]The shares underlying the options vest one year after the date of grant on August 17, 2023, subject to the Reporting Person's continuous service to the Issuer as of such date.

Issuer

Immunovant, Inc.

CIK 0001764013

Entity typeother

Related Parties

1
  • filerCIK 0001341896

Filing Metadata

Form type
4
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 4:48 PM ET
Size
7.4 KB